44
Participants
Start Date
April 13, 2021
Primary Completion Date
January 17, 2023
Study Completion Date
January 17, 2023
Rituximab
Rituximab (375 mg/m2) will be given as a single intravenous infusion after remission
Children's Hospital of Fudan University, Shanghai
Anhui Provincial Children's Hospital, Hefei
Children's Hospital Affiliated to Zhengzhou University/Henan Children's Hospital, Zhengzhou
Wuhan Children's Hospital,Tongji Medical College, Huazhong University of Science and Technology., Wuhan
Children's Hospital of Nanjing Medical University, Nanjing
The First Affiliated Hospital of Zhongshan University, Guanzhou
Shandong Provincial Hospital Affiliated to Shandong University, Shandong
Xuzhou Children's Hospital, Xuzhou
Children's Hospital of Nanjing Medical University
OTHER
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
OTHER
Anhui Provincial Children's Hospital
OTHER
Children's Hospital Affiliated to Zhengzhou University/Henan Children's Hospital
UNKNOWN
The first affiliated hospital of Zhongshan university
UNKNOWN
Shandong Provincial Hospital
OTHER_GOV
Xuzhou Children Hospital
OTHER
Children's Hospital of Fudan University
OTHER